Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Meet the New Wave of Therapeutic Antibodies

| Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Discovery & Development Drug Discovery

Retinal Regeneration

| 3 min read

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

Discovery & Development Drug Discovery

The Antibody Saga – Key Milestones and Big Predictions

| Sponsored by Bio-Rad Laboratories | 8 min read

Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development

Discovery & Development Drug Discovery

The Antibody Discovery Challenge

| Sponsored by Bio-Rad Laboratories | 6 min read

What lies ahead for antibody discovery? We ask experts from RQ Bio.

Discovery & Development Drug Discovery

Time for (CAR) T

| Stephanie Vine | 6 min read

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

Discovery & Development Drug Discovery

James Phipps, We Salute You

| Rob Coker | 3 min read

It’s been 200 years since the death of Edward Jenner – but how best to celebrate his achievement?

Discovery & Development Drug Discovery

Maps for Drug Discovery

| Stephanie Vine | 3 min read

A new technology called ASCEND is being using to help pharmaceutical research.

Discovery & Development Drug Delivery

International Rescue

| Rob Coker | 3 min read

The International Vaccine Institute’s Youngmi Cho is on a mission to protect communities against diseases of poverty

Discovery & Development Drug Discovery

To Be Precise

| Neil Ward | 3 min read

Better data brings new advances in our knowledge of genetics. PacBio VP Neil Ward explains how pharmacogenomics will accelerate precision medicine.

Discovery & Development Drug Discovery

Flying with the FALCON

| Arthur T Suckow | 5 min read

A start up company explains how their platform is helping to boost RNA therapeutics.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register